Journal
Found vs Calibrate for tirzepatide: price, terms and 12-month cost (November 2026)
One sells compounded tirzepatide with the medication inside the price; the other sells a membership and leaves the brand drug to your insurance or your wallet.
Found sells compounded tirzepatide from $239 per 28-day cycle on a 12-month cash plan ($359 month to month) with medication included, while Calibrate charges a $199 monthly membership with a three-month minimum, prescribes only brand GLP-1s and excludes the drug, per both companies' pages read November 9, 2026. Your insurance decides which costs less.
The short answer
These two programs do not sell the same thing. Found's tirzepatide plans use compounded tirzepatide: made with the drug in Zepbound, not the same product, and not FDA-approved. The medication, clinician care and membership come in one price per 28-day cycle. Calibrate does not prescribe compounded GLP-1s at all. Its $199-a-month membership pays for coaching and clinician visits. The medication is a brand drug such as Zepbound or Mounjaro, paid through insurance or bought separately.
The deciding question: does a commercial insurance plan cover a brand GLP-1 for you? If it does, Calibrate's route can cost less over a year. If it does not, Found's compounded plans cost thousands of dollars less than Calibrate plus self-pay Zepbound.
What we read, and when
We read both companies' own pages on November 9, 2026: Found's offer terms, pricing page and compounded tirzepatide page, and Calibrate's pricing page, membership terms, medication page, FAQs, cancellation policy and money-back promise.
Found's store page was unreadable on November 9; its prices below come from the offer terms read that day and match our October 15, 2026 store-page read. Brand Zepbound prices come from Lilly's Zepbound savings page (CMAT-26402 09/2026), also read November 9.
Found vs Calibrate side by side
| What you are comparing | Found | Calibrate |
|---|---|---|
| Tirzepatide offered | Compounded tirzepatide (not FDA-approved) | Brand only (Zepbound, Mounjaro); "we do not prescribe compounded GLP-1 medications" |
| Medication in the price | Yes, on compounded plans | No; medication and labs are separate |
| Program or membership fee | Included in the per-cycle price | $199 a month |
| Billing | Every 4 weeks (28-day cycle), so 13 charges a year | Monthly |
| Minimum commitment | None on the 1-month plan; 3, 6 and 12-month plans cost less per cycle | 3 months ($597 in three installments), then month to month |
| Lowest standing tirzepatide price | $239 per cycle (cash, 12-month plan); $179 (insurance column) | $199 membership plus the drug's cost |
| Month-to-month price | $359 cash after a $219 first cycle; $289 insurance column after $149 | $199 plus the drug, after the 3-month minimum |
| Same price at every dose | Yes ("one flat price") | Depends on your insurance or the brand's self-pay price |
| Insurance | Lower price column for commercial insurance; not for government plans; copays may apply | Does not bill insurance itself; works to get your plan to cover the drug |
| Pharmacy disclosed | "Licensed 503A compounding pharmacies," not named on pages read | Brand drug filled through your pharmacy benefit |
| States | "Not available in all states"; California shows no insurance plans | "All 50 states and D.C." |
| Weight-loss guarantee | None on the pages read | 50% of membership fees back after 12 months under 10% loss, with conditions |
Found's tirzepatide prices, cycle by cycle
Found prints two price columns: cash, and a lower column for members with commercial insurance. Found's offer terms say it is not available to people with government plans, and that copays, coinsurance and deductibles may apply. Its pricing page adds that insurance members need video visits, with a copay "typically around $30" each on top of the plan price.
| Plan | Cash per cycle | Insurance column per cycle | Cash, 13 cycles | Insurance column, 13 cycles |
|---|---|---|---|---|
| 1 month | $219 first, then $359 | $149 first, then $289 | $4,527 | $3,617 |
| 3 months | $309 | $239 | $4,017 | $3,107 |
| 6 months | $289 | $209 | $3,757 | $2,717 |
| 12 months | $239 | $179 | $3,107 | $2,327 |
Found bills every four weeks, not every calendar month. Thirteen cycles cover 364 days, so a year holds 13 charges, not 12. The 3- and 6-month rows assume you renew at the same rate, which the terms do not promise. The insurance column excludes visit copays.
Found's compounded tirzepatide page says the price "stays the same at every dose." It says Found "partners exclusively with licensed 503A compounding pharmacies" but does not name them on the pages we read.
In our tirzepatide price index of 28 compounded programs (October 15, 2026 dataset), the all-in lowest monthly price runs from $86 to $280, with a median of $144. Found's lowest cash price, $239, sits $95 above that median.
What Calibrate charges, and what it leaves out
Calibrate's pricing page reads "$199/month (3-month commitment required)," and the page puts the total at $597 paid in three monthly installments. After three months the membership renews one month at a time.
The membership includes a 20-minute video clinician visit with lab review, ongoing access to medical and support teams, 1:1 video coaching and a smart scale. The page states that lab tests and prescription medications are not included in the membership cost.
Calibrate's medication page names Zepbound, Mounjaro, Wegovy and Foundayo and says "we do not prescribe compounded GLP-1 medications." Its membership terms say Calibrate "does not participate with or bill commercial health insurance plans," but its team works to get your plan to cover the medication. Its FAQs say GLP-1s for most members with commercial insurance are "typically capped at $25 per month after any deductible is met." The membership fee itself is not covered by insurance, though it is HSA/FSA eligible.
If your plan does not cover the drug, Calibrate's FAQs say "more affordable self-pay options" are reviewed at your visit. They do not name a channel or a price. Lilly's own self-pay card for the Zepbound KwikPen or vial lists $299 at 2.5 mg, $399 at 5 mg and $449 at 7.5 to 15 mg with each refill within 45 days. If a refill comes later than that, the price is $499 at 7.5 mg and $699 at 10 to 15 mg. The card allows 11 fills a calendar year, and its savings end December 31, 2026. More on the card in our Zepbound savings card guide.
Twelve months, six ways
| Route | Program fees | Medication | 12-month total |
|---|---|---|---|
| Found cash, 12-month plan | 13 × $239 = $3,107 | Included | $3,107 |
| Found cash, month to month | $219 + 12 × $359 = $4,527 | Included | $4,527 |
| Calibrate, brand drug covered at $25 | 12 × $199 = $2,388 | 12 × $25 = $300 | $2,688 plus deductible and labs |
| Calibrate, Zepbound self-pay | 12 × $199 = $2,388 | $299 + $399 + 10 × $449 = $5,188 | $7,576 plus labs |
| NexLife, 12-month plan | $0 (no membership) | 12 × $115 = $1,380 | $1,380 |
| NexLife, month to month | $0 (no membership) | 12 × $129 = $1,548 | $1,548 |
The self-pay row assumes one month at 2.5 mg, one at 5 mg, then ten at 7.5 mg or higher, with every refill within 45 days. It illustrates the price ladder, not dosing advice; your clinician sets your dose. Lilly's card savings end December 31, 2026, and Lilly has not published 2027 prices, so any 12 months that start now run past that date.
With coverage at $25, Calibrate costs $3,107 − $2,688 = $419 less than Found's 12-month cash plan, before your deductible and labs. If your deductible is more than $419, that gap is gone. Without coverage, Calibrate plus self-pay Zepbound costs $7,576 − $4,527 = $3,049 more than Found's month-to-month cash plan.
If you stop early
Calibrate's initial term is three months. Its terms say it does not refund a term you have already paid for, and they do not waive installments you have not yet paid. Its cancellation policy offers a full refund of membership fees only within 72 hours of purchase. After that, you must cancel at least 7 calendar days before your next billing date.
Found's 1-month plan has no minimum. Found recommends cancelling at least 48 hours before renewal. Its membership fee is refundable only if you cancel within 3 days of purchase or before your first consultation. Medication cannot be refunded once it ships, and renewal payments are non-refundable. The offer terms print no refund schedule for multi-month plans, and Found's pricing page says its 12-month prices are "based on 12-month plans paid up-front."
Say you stop after eight weeks. On Found's month-to-month cash plan you would have paid $219 + $359 = $578, with medication included. At Calibrate you still owe the $597 minimum. Add self-pay Zepbound at $299 + $399 and the total is $1,295. With coverage at $25 a month it is $597 + $50 = $647.
The money-back promise, read closely
Calibrate's Results Money Back Promise refunds 50% of the membership fees you paid if you do not lose at least 10% of your body weight after 12 consecutive months. It excludes medication, labs and third-party charges. It applies only if you paid for yourself and joined after May 16, 2024. You must also not have taken prescription weight-loss medication in the 12 months before joining, and you must have followed the "Calibrate Commitment." After 12 months at $199, half of the fees is $2,388 ÷ 2 = $1,194. That is the most the promise can return. It is a refund policy, not a prediction of results.
The Found pages we read did not include a weight-loss guarantee for tirzepatide plans.
Who each program suits
- Found suits you if you have no coverage for a brand GLP-1, want the medication inside one price, and want to be able to leave from month to month. You are accepting a compounded drug that is not FDA-approved.
- Calibrate suits you if a commercial plan covers Zepbound or another brand GLP-1, you want scheduled coaching, and you can commit to three months of fees.
- Neither is built for Medicare. Found's insurance column excludes government plans, and Calibrate's fee is not covered by insurance. Medicare's $50-copay GLP-1 Bridge (July 1, 2026 to December 31, 2027) covers the Zepbound KwikPen, not vials. People with type 2 diabetes, moderate-to-severe sleep apnea or fatty liver disease are not eligible, though their Part D plan "might cover" a GLP-1. See our Medicare GLP-1 Bridge guide.
What this means for you
If your plan covers Zepbound after a deductible. A year at Calibrate costs $2,688 plus whatever you pay toward the deductible. Compared with Found's 12-month cash plan ($3,107), Calibrate stays cheaper while that deductible spending is under $419. Compared with Found's month-to-month cash plan ($4,527), it stays cheaper while the deductible spending is under $4,527 − $2,688 = $1,839. Ask your plan about the deductible and prior authorization.
If you have no coverage but want an FDA-approved drug. Twelve fills of Zepbound at Lilly's current self-pay prices come to $5,188 whichever program writes the prescription. Calibrate's membership adds $7,576 − $5,188 = $2,388 for coaching and visits. Decide whether that support is worth $199 a month to you. Our brand vs compounded tirzepatide guide covers the trade-offs.
If you are fine with compounded tirzepatide but unsure you will stay. Found's 12-month cash plan saves $4,527 − $3,107 = $1,420 over the month-to-month plan if you stay the full 364 days. But if you pay for the year up front, the offer terms print no refund schedule for unused months. Paying $578 for the first eight weeks month to month keeps your exit open.
Check the checkout price against these figures, count 13 four-week charges for Found, and ask for the total at your expected dose. Our profiles of Found and Calibrate and the Calibrate vs Found comparison carry the rest of our records. This site's editors' pick, NexLife, lists compounded tirzepatide at $129 month to month and $115 a month on a 12-month plan (read November 6, 2026); see its profile.
Sources
- Offer Terms (Last Updated Aug 26, 2025) · Found Health, Inc. · read November 9, 2026
- Plans and Pricing · Found Health, Inc. · read November 9, 2026
- Compounded Tirzepatide · Found Health, Inc. · read November 9, 2026
- Compounded Tirzepatide store page (not re-read on 2026-11-09; carried from first-party read) · Found Health, Inc. · read October 15, 2026
- Pricing · Calibrate Health · read November 9, 2026
- Membership Terms and Conditions (Last updated October 23, 2025) · Calibrate Health · read November 9, 2026
- Medication · Calibrate Health · read November 9, 2026
- FAQs · Calibrate Health · read November 9, 2026
- The Calibrate Results Money Back Promise (Last updated May 16, 2024) · Calibrate Health · read November 9, 2026
- Cancellation Policy (Last updated May 17, 2024) · Calibrate Health · read November 9, 2026
- Zepbound coverage and savings (CMAT-26402 09/2026) · Eli Lilly and Company · read November 9, 2026
- Medicare GLP-1 Bridge · Medicare.gov (CMS) · read November 9, 2026
- FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss (content current as of 10/01/2026) · U.S. Food and Drug Administration · read November 9, 2026
Questions readers actually ask
Does Calibrate offer compounded tirzepatide?
No. Calibrate's medication page says "we do not prescribe compounded GLP-1 medications." Its clinicians prescribe brand drugs such as Zepbound and Mounjaro, which you pay for through your insurance or buy separately. The $199 monthly membership covers coaching and clinician visits, not the medication or lab tests. If your plan does not cover a brand GLP-1, the drug's own self-pay price is added on top of the membership.
How much does Found charge for compounded tirzepatide?
Found's offer terms, read November 9, 2026, list cash prices of $359 per 28-day cycle month to month (after a $219 first cycle), $309 on a 3-month plan, $289 on 6 months and $239 on 12 months. A lower insurance column runs $289, $239, $209 and $179 for members with commercial insurance, plus visit copays. Medication and membership are included, and the price is the same at every dose.
Which is cheaper over a year, Found or Calibrate?
It depends on insurance. With a brand GLP-1 covered at $25 a month, a year at Calibrate is $2,688 before deductible and labs, versus $3,107 on Found's 12-month cash plan. Without coverage, Calibrate plus self-pay Zepbound at Lilly's current card prices comes to $7,576, versus $4,527 on Found's month-to-month cash plan. These are worked examples from published prices read November 9, 2026, not quotes.
Can I cancel Found or Calibrate at any time?
Found's 1-month plan has no minimum; it recommends cancelling at least 48 hours before renewal, and shipped medication is non-refundable. Calibrate requires a three-month initial term at $199 a month, offers a full refund only within 72 hours of purchase, and asks for 7 calendar days' notice before the next billing date. After the first three months Calibrate renews one month at a time and can be cancelled.
Is compounded tirzepatide from Found the same as Zepbound?
No. Compounded tirzepatide is made with the drug in Zepbound, but it is not the same product, it is not a generic, and it is not FDA-approved. Found's own page says compounded GLP-1s are "not FDA-approved or evaluated for safety or efficacy." FDA says compounded drugs should only be used when an FDA-approved drug cannot meet a patient's medical needs. Ask your clinician which option suits you.
Related on this site
- The journalJournal
- Retatrutide Phase 3 Results: What Changed in July 2026Journal
- FDA Compounded GLP-1 Rules in 2026Journal
- How to Spot Fraudulent Compounded GLP-1 LabelsJournal
- How rankings are computedCore & Trust
- All-in cost toolTools
- Price records, machine-readableData
- Tirzepatide Price by DosePillar / Money
- Microdose vs Standard-Dose TirzepatideComparisons
- Microdose Tirzepatide: Evidence, Cost and LimitationsPillar / Money
Related coverage
Tirzepatide Ranked. “How Dose Escalation Changes Tirzepatide Cost.” S.J Partners LLC, 2026-07-26. https://tirzepatideranked.com/journal/found-vs-calibrate-tirzepatide/
Quote the capture date beside a figure, not the date you read this page. Why.
How current these prices are: on November 20, 2026 we re-read the sellers’ own pages for 29 of the 33 compounded tirzepatide programs in our price index; the other 4 are older dated records we could not re-read that day. NexLife’s prices, unchanged since November 6, 2026, were re-read the same day. Any older figure on this page keeps the date it was read.